Back
OncoCyte Quote, Financials, Valuation and Earnings
Sponsored
OCX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
OCX
OncoCyte
Last Price:
2.49
Seasonality Move:
42.9%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.OncoCyte Price Quote
$2.49
-0.04 (-5.68%)
(Updated: November 27, 2024 at 5:33 AM ET)
OncoCyte Key Stats
Sell
43
OncoCyte (OCX)
is a Sell
Day range:
$2.50 - $2.79
52-week range:
$2.29 - $4.19
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
38.46
P/B ratio:
4.39%
Volume:
71.4K
Avg. volume:
53K
1-year change:
-40.05%
Market cap:
$42.6M
Revenue:
$1.5M
EPS:
$-4.54
How Much Does OncoCyte Make?
Is OncoCyte Growing As A Company?
OncoCyte Stock Price Performance
What Is OncoCyte 52-Week High & Low?
OncoCyte Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy OncoCyte?
Is OncoCyte Cash Flow Positive?
OncoCyte Return On Invested Capital
OncoCyte Earnings Date & Stock Price
-
What Is OncoCyte's Stock Price Today?
A single share of OCX can be purchased today for 2.53 -
What Is OncoCyte’s Stock Symbol?
OncoCyte trades on the nasdaq under the ticker symbol: OCX -
When Is OncoCyte’s Next Earnings Date?
The next quarterly earnings date for OncoCyte is scheduled on April 11, 2025 -
When Is OCX's next ex-dividend date?
OncoCyte's next ex-dividend date is November 27, 2024 -
How To Buy OncoCyte Stock?
You can buy OncoCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
OncoCyte Competitors
OncoCyte Dividend Yield
-
What Is OCX Dividend Yield?
OncoCyte’s dividend yield currently is 0% -
What Is OncoCyte’s Payout Ratio?
OncoCyte’s payout ratio is 0% -
When Did OncoCyte Last Pay A Dividend?
The latest dividend pay date is November 27, 2024 -
What Is OncoCyte’s Dividend Per Share?
OncoCyte pays a dividend of $0.00 per share
OncoCyte Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | -73.19% | -31.68% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 4.25 |
Upside from Last Price: | 67.98% |